DPH.L - Dechra Pharmaceuticals PLC
| Previous close | 2,914.00 |
| Open | 2,860.00 |
| Bid | 2,914.00 x 0 |
| Ask | 2,912.00 x 0 |
| Day's range | 2,860.00 - 2,952.00 |
| 52-week range | 388.00 - 3,090.00 |
| Volume | 150,238 |
| Avg. volume | 357,178 |
| Market cap | 3.132B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 104.32 |
| EPS (TTM) | 27.80 |
| Earnings date | 07 Sep 2020 |
| Forward dividend & yield | 0.32 (1.11%) |
| Ex-dividend date | 05 Mar 2020 |
| 1y target est | 2,680.86 |
- Simply Wall St.
Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
- Stockopedia
As Dechra Pharmaceuticals hits a yearly high, is it too late to buy shares?
With shares in Dechra Pharmaceuticals (LON:DPH) currently trading close to a 52 week high, a question many on the sidelines probably have is: quot;was I too l...
- Simply Wall St.
Does Dechra Pharmaceuticals PLC's (LON:DPH) CEO Pay Reflect Performance?
Ian Page has been the CEO of Dechra Pharmaceuticals PLC (LON:DPH) since 2001. This analysis aims first to contrast CEO...
- Stockopedia
As Dechra Pharmaceuticals (LON:DPH) hits a new 52-week high, what should shareholders do?
It's difficult to pick your own shares successfully – research consistently shows that more than half of retail investors in the UK and US who pick their own s8230;
- Simply Wall St.
Are Investors Undervaluing Dechra Pharmaceuticals PLC (LON:DPH) By 21%?
How far off is Dechra Pharmaceuticals PLC (LON:DPH) from its intrinsic value? Using the most recent financial data...
- Simply Wall St.
Dechra Pharmaceuticals PLC Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Last week saw the newest half-yearly earnings release from Dechra Pharmaceuticals PLC (LON:DPH), an important...
- Simply Wall St.
Read This Before Judging Dechra Pharmaceuticals PLC's (LON:DPH) ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- Simply Wall St.
Is Dechra Pharmaceuticals PLC (LON:DPH) A Great Dividend Stock?
Could Dechra Pharmaceuticals PLC (LON:DPH) be an attractive dividend share to own for the long haul? Investors are...
- Simply Wall St.
Is Dechra Pharmaceuticals's (LON:DPH) 240% Share Price Increase Well Justified?
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a...
- Simply Wall St.
Dechra Pharmaceuticals PLC (LON:DPH) Stock Goes Ex-Dividend In Just 3 Days
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- Simply Wall St.
How Should Investors React To Dechra Pharmaceuticals PLC's (LON:DPH) CEO Pay?
Ian Page became the CEO of Dechra Pharmaceuticals PLC (LON:DPH) in 2001. This report will, first, examine the CEO...
- Simply Wall St.
What Should You Know About The Future Of Dechra Pharmaceuticals PLC's (LON:DPH)?
After Dechra Pharmaceuticals PLC's (LON:DPH) earnings announcement on 30 June 2019, analyst consensus outlook appear...
- Reuters
Dechra ramps up contingency plan for a potential hard Brexit
The company said it shifted all the analytical testing methods for products made at its site in Skipton, England, to a new lab in Zagreb, Croatia and to its existing Bladel laboratory in southern Netherlands. "This will allow us to perform batch release within the EU in the likely event that there will be no mutual recognition of quality standards," Dechra said in a statement.
- Simply Wall St.
Is Dechra Pharmaceuticals (LON:DPH) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
- Simply Wall St.
What You Should Know About Dechra Pharmaceuticals PLC's (LON:DPH) Financial Strength
While small-cap stocks, such as Dechra Pharmaceuticals PLC (LON:DPH) with its market cap of UK£3.0b, are popular for...
